← All stocks

bioAffinity Technologies, Inc.

BIAF No buying or selling
CIK 0001712762 #5518 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

5 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GIRGENTI STEVEN
Executive Chairman
1,080,062
+1.4%
Zannes Maria
President & CEO
280,359
+15.2%
Edwards James Michael
VP and CFO
120,128
+760.8%
Zannes Timothy P
Secretary, EVP, Gen. Counsel
54,765
+18.7%
Reveles Xavier Trinidad
Chief Operating Officer
41,943
+106.2%

No percentages here. This company's share count has moved by a factor of 6.3 over the window, from 4,498,675 to 28,468,612 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Oct 2022